Soft Tissue Sarcoma of the Extremity

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-11-18
Clinical Trial Update: A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity [Phase 2]
A Phase 2 randomized trial evaluating pembrolizumab plus radiotherapy versus radiotherapy alone in high-risk soft tissue sarcoma of the extr…